Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5966 studies found for:    "Lymphatic Diseases"
Show Display Options
Rank Status Study
1 Completed Effectiveness of Intracavitary Manual Lymphatic Drainage
Condition: Lymphatic Diseases
Interventions: Other: Intracavitary Manual Lymphatic Drainage;   Other: Conventional treatment
2 Not yet recruiting Phase II Study About Combination CHOP-21, Obinutuzumab and Ibrutinib in Untreated Young High Risk DLBCL Patients.
Condition: Lymphatic Diseases
Interventions: Drug: Obinutuzumab;   Drug: Ibrutinib;   Drug: CHOP
3 Recruiting A Phase II Study With Bendamustine Plus Brentuximab Vedotin in Hodgkin's Lymphoma and CD30+ Peripheral T-cell Lymphoma in First Salvage Setting: the BBV Regimen
Condition: Lymphatic Diseases
Interventions: Drug: Brentuximab Vedotin;   Drug: Bendamustine
4 Recruiting Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients
Condition: Lymphatic Diseases
Intervention: Drug: Brentuximab Vedotin
5 Recruiting International Lymphatic Disease and Lymphedema Registry
Condition: Lymphedema
Intervention:
6 Recruiting Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
Conditions: Lymphatic Diseases;   Hematopoietic Malignancy
Intervention: Biological: Umbilical Cord Blood (UCB)
7 Completed A Study of Isoprinosine in Patients With Lymph Node Disease
Conditions: Lymphatic Disease;   HIV Infections
Intervention: Drug: Inosine pranobex
8 Completed The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease
Conditions: Lymphatic Disease;   HIV Infections
Intervention: Drug: Inosine pranobex
9 Completed A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy
Conditions: Lymphatic Disease;   HIV Infections
Intervention: Drug: Inosine pranobex
10 Completed The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)
Conditions: Lymphatic Disease;   HIV Infections
Intervention: Drug: Zidovudine
11 Recruiting Sildenafil for the Treatment of Lymphatic Malformations
Conditions: Lymphatic Malformations;   Lymphatic Diseases
Interventions: Drug: Sildenafil 20 mg tablets;   Other: Placebo tablets (resembling Revatio)
12 Enrolling by invitation Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
Conditions: Lymphedema;   Lymphatic Disorders;   Lipedema;   Vascular Malformation;   Vascular Anomaly
Intervention: Drug: NIRFLI with ICG
13 Recruiting Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
Conditions: Lymphangiomatosis;   Lymphedema;   Lymphangiectasia;   Pulmonary Lymphangiectasia
Intervention:
14 Enrolling by invitation Imaging of Lymphatic Anomalies
Conditions: Gorham Disease;   Lymphatic Diseases;   Lymphangiomatosis
Interventions: Other: Dynamic Contrast Enhanced Magnetic Resonance Lymphangiography (DCMRL);   Other: Heavy Weighted T2 Imaging (T2W);   Other: Lymph Node Access
15 Completed Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder
Intervention: Drug: Pyrimethamine
16 Completed Ultrasound-Guided Needle Biopsy in the Diagnosis of Malignant Cervical Lymphadenopathies
Conditions: Lymphadenopathy;   Malignancy
Intervention:
17 Completed A Real-time and Computerized Sonographic Reporting System in Predicting Malignant Cervical Lymphadenopathy
Condition: Lymphadenopathy
Intervention:
18 Completed Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Aldesleukin
19 Not yet recruiting Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development
Condition: Lymphedema
Intervention: Drug: Indocyanine Green (ICG)
20 Enrolling by invitation Hyperbaric Oxygen Therapy to Reduce Lymphedema After Breast Cancer -an Explorative Clinical Trial
Condition: Secondary Lymphedema
Intervention: Drug: Medical Oxygen

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.